The Perimenopause You Weren’t Warned About

Welcome back. In the first episode, we talked about what's happening to your body during perimenopause: muscle loss, fat redistribution, metabolic shifts. But today we're going to talk about something that might feel even more disorienting—the fact that this entire transition can feel invisible to the medical system.

Here's what surveys consistently find: a substantial minority of women with perimenopause symptoms leave their first clinical visit without a diagnosis. That absence of diagnosis is a real problem. Because when you don't have a name for what's happening, when a doctor hasn't validated it, it's easy to blame yourself. You start to think: maybe I'm just getting older. Maybe I need to try harder. Maybe this is just life.

But it's not. It's a specific biological transition. And it has a name.

The transition into menopause is called perimenopause. Menopause itself is a single point in time—the moment you've gone 12 consecutive months without a period. But the transition leading up to it—perimenopause—can begin as early as the mid-to-late 30s and last a decade or longer, sometimes over 15 years for some women. For most women, it begins in the early 40s and lasts 4 to 8 years on average.

During perimenopause, your ovaries are gradually releasing fewer eggs. Your periods become irregular. You might go three months without a period and think it's over, and then it comes back. You might have a period that's much heavier than usual, or much lighter. You might skip one and then have two in a month. This irregularity is the hallmark of perimenopause.

And it matters—not just because it's confusing, but because it's a marker of what's happening hormonally. Your estrogen and progesterone are fluctuating wildly. That hormonal instability is driving the body changes we talked about in Episode 1, but it's also driving other symptoms: hot flashes, night sweats, sleep disruption, mood changes, brain fog.

Now, how do clinicians know where you are in this transition? There's actually a system for this. It's called the Stages of Reproductive Aging Workshop, or STRAW—a staging system updated in 2012 (STRAW+10, Harlow et al., Menopause 2012)—that helps clinicians recognize exactly where in the transition you are. STRAW divides the menopausal transition into stages based on menstrual regularity, hormone levels, and symptoms. It sounds clinical, but the point is simple: your perimenopause isn't just a blur of unpredictability. It's a staged biological process that can be tracked and understood.

One thing that surprises a lot of women: approximately 75-80% of women report hot flashes or night sweats during perimenopause. So if you're having those symptoms, you're not alone. You're in the majority. This data comes from the SWAN study—the Study of Women's Health Across the Nation—which has followed thousands of women through this transition and has become the gold standard for understanding perimenopause.

Now, let's talk about the medical narrative around menopause and hormones, because this has shifted significantly over the past 20 years.

In 2002, a large study called the Women's Health Initiative, or WHI, published results that caused many doctors to pull back from prescribing hormone therapy. The study found that hormone therapy was associated with increased cardiovascular risk in the women studied. It was a landmark finding, and it changed practice overnight.

But here's what changed: that study was re-analyzed in subsequent years, and the picture became more nuanced. Long-term WHI follow-up analyses (Manson et al., JAMA 2017) and the NAMS 2022 Hormone Therapy Position Statement support what's now called the "timing hypothesis": the age at which you start hormone therapy matters enormously. Women starting hormone therapy before age 60 or within 10 years of menopause—in other words, women in their 50s at the start of this transition—have a more favorable cardiovascular profile than women who start therapy later.

This doesn't mean everyone should take hormone therapy. It means the risk-benefit picture is different in midlife than it is in older women. If you're in your late 40s or early 50s and you start hormone therapy, the cardiovascular risk is actually lower than if you wait until you're older.

That nuance matters. Because many women have been told hormone therapy is off the table, when in fact the evidence supports its use during the menopausal transition, at least for certain women.

Let me circle back to the beginning: What you're experiencing—the night sweats, the brain fog, the mood changes, the irregular periods—they're all part of a predictable biological transition that 75% of women go through. When you understand that this is a stage—STRAW staging can name it—you can make better decisions. You can talk to a clinician who understands perimenopause. You can ask about options: lifestyle changes, behavioral strategies, hormone therapy, non-hormone alternatives. You're no longer in the dark.

The biggest gift of understanding perimenopause is this: it's not a failure on your part. It's a transition. And transitions, by definition, are something you move through.